What does Kaken Pharmaceutial do with its cash?

Cash vs. profit gap

-¥13.2B（純利益の -616.7%）

Shareholder returns

of net income 412.4%

Shareholder payments — dividends

of net income 303.1%

CapEx intensity (capex ÷ revenue)

7.1%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

• Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
• Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
• Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.